HRP20080292T3 - Preparation of cabergoline form i and solvate thereof - Google Patents
Preparation of cabergoline form i and solvate thereofInfo
- Publication number
- HRP20080292T3 HRP20080292T3 HR20080292T HRP20080292T HRP20080292T3 HR P20080292 T3 HRP20080292 T3 HR P20080292T3 HR 20080292 T HR20080292 T HR 20080292T HR P20080292 T HRP20080292 T HR P20080292T HR P20080292 T3 HRP20080292 T3 HR P20080292T3
- Authority
- HR
- Croatia
- Prior art keywords
- cabergoline
- solvate
- preparation
- solvent
- cabergoline form
- Prior art date
Links
- KORNTPPJEAJQIU-KJXAQDMKSA-N Cabaser Chemical group C1=CC([C@H]2C[C@H](CN(CC=C)[C@@H]2C2)C(=O)N(CCCN(C)C)C(=O)NCC)=C3C2=CNC3=C1 KORNTPPJEAJQIU-KJXAQDMKSA-N 0.000 title abstract 8
- 239000012453 solvate Substances 0.000 title abstract 4
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 abstract 4
- 229960004596 cabergoline Drugs 0.000 abstract 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 abstract 3
- 239000002904 solvent Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
- C07D457/06—Lysergic acid amides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Secondary Cells (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0409785.3A GB0409785D0 (en) | 2004-04-30 | 2004-04-30 | Preparation of cabergoline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20080292T3 true HRP20080292T3 (en) | 2008-07-31 |
Family
ID=32482531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20080292T HRP20080292T3 (en) | 2004-04-30 | 2008-06-23 | Preparation of cabergoline form i and solvate thereof |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US7186837B2 (el) |
| EP (1) | EP1591445B1 (el) |
| JP (1) | JP2007535526A (el) |
| AT (1) | ATE394397T1 (el) |
| AU (1) | AU2005238276B2 (el) |
| CA (1) | CA2565440C (el) |
| CY (1) | CY1108244T1 (el) |
| DE (1) | DE602005006465D1 (el) |
| DK (1) | DK1591445T3 (el) |
| ES (1) | ES2304670T3 (el) |
| GB (1) | GB0409785D0 (el) |
| HR (1) | HRP20080292T3 (el) |
| NZ (1) | NZ550925A (el) |
| PL (1) | PL1591445T3 (el) |
| PT (1) | PT1591445E (el) |
| RS (1) | RS50655B (el) |
| SI (1) | SI1591445T1 (el) |
| WO (1) | WO2005105796A1 (el) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60236600D1 (de) | 2001-08-13 | 2010-07-15 | Du Pont | Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung |
| US7531551B2 (en) * | 2003-05-08 | 2009-05-12 | Ivax Pharmaceuticals S.R.O. | Polymorphs of cabergoline |
| GB0409785D0 (en) | 2004-04-30 | 2004-06-09 | Resolution Chemicals Ltd | Preparation of cabergoline |
| GB0505965D0 (en) | 2005-03-23 | 2005-04-27 | Resolution Chemicals Ltd | Preparation of cabergoline |
| US7339060B2 (en) | 2005-03-23 | 2008-03-04 | Resolution Chemicals, Ltd. | Preparation of cabergoline |
| EP1925616A1 (en) * | 2006-10-26 | 2008-05-28 | LEK Pharmaceuticals D.D. | Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline |
| EP1953157A1 (en) | 2007-01-31 | 2008-08-06 | LEK Pharmaceuticals D.D. | New crystal form of cabergoline |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH535236A (de) | 1970-06-19 | 1973-03-31 | Sandoz Ag | Verfahren zur Herstellung neuer reaktionsträger Lysergsäurederivate |
| CH535235A (de) | 1970-06-19 | 1973-03-31 | Sandoz Ag | Verfahren zur Herstellung neuer reaktionsträger Lysergsäurederivate |
| US3920664A (en) * | 1972-07-21 | 1975-11-18 | Lilly Co Eli | D-2-halo-6-alkyl-8-substituted ergolines and related compounds |
| PH11140A (en) | 1973-11-28 | 1977-10-27 | Lilly Co Eli | D-6-alkyl-2,8-disubstituted ergolines and a process for inhibiting the secretion of prolactin in mammals |
| CH587858A5 (el) * | 1973-11-28 | 1977-05-13 | Sandoz Ag | |
| DE2525962A1 (de) | 1974-06-21 | 1976-01-08 | Sandoz Ag | Neue heterocyclische verbindungen, ihre herstellung und verwendung |
| US4166182A (en) | 1978-02-08 | 1979-08-28 | Eli Lilly And Company | 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds |
| US4180582A (en) * | 1978-02-08 | 1979-12-25 | Eli Lilly And Company | 6-n-Propyl-8-methoxy-methyl or methylmercaptomethylergolines and related compounds as prolactin inhibitors and to treat Parkinson's syndrome |
| US4202979A (en) * | 1979-01-11 | 1980-05-13 | Eli Lilly And Company | 6-Ethyl(or allyl)-8-methoxymethyl or methylmercaptomethylergolines and related compounds |
| US4246265A (en) * | 1979-10-01 | 1981-01-20 | Eli Lilly And Company | 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds |
| NL189462C (nl) | 1980-04-03 | 1993-04-16 | Erba Carlo Spa | Ergolinederivaten met antiprolactinische en/of antihypertensieve eigenschappen en farmaceutische preparaat daarvan. |
| US4526892A (en) * | 1981-03-03 | 1985-07-02 | Farmitalia Carlo Erba, S.P.A. | Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas |
| AU553809B2 (en) * | 1981-07-21 | 1986-07-31 | Farmitalia Carlo Erba S.P.A. | Ergoline derivatives |
| GB2103603B (en) | 1981-08-11 | 1985-04-11 | Erba Farmitalia | Ergoline derivatives |
| US4782152A (en) * | 1985-08-16 | 1988-11-01 | Eli Lilly And Company | Decyanation of pergolide intermediate |
| GB9205439D0 (en) * | 1992-03-12 | 1992-04-22 | Erba Carlo Spa | Process for the synthesis of ergoline derivatives |
| CZ287176B6 (cs) | 1997-10-03 | 2000-10-11 | Galena A. S. | Způsob přípravy ergolinových derivátů |
| IT1307934B1 (it) * | 1999-01-27 | 2001-11-29 | Poli Ind Chimica Spa | Processo per la preparazione di derivati alchimercaptometilergolinici. |
| GB0007307D0 (en) | 2000-03-24 | 2000-05-17 | Pharmacia & Upjohn Spa | Crystalline form || of cabergoline |
| GB0007308D0 (en) | 2000-03-24 | 2000-05-17 | Pharmacia & Upjohn Spa | Process for preparing crystalline form | of cabergoline |
| GB0007309D0 (en) | 2000-03-24 | 2000-05-17 | Pharmacia & Upjohn Spa | Crystalline form V|| of cabergoline |
| AU2003218753A1 (en) | 2002-03-15 | 2003-09-29 | Pharmacia Corporation | Process for preparing crystalline form i of cabergoline |
| PL372371A1 (en) | 2002-03-15 | 2005-07-25 | Pharmacia Corporation | Process for preparing crystalline form i of cabergoline |
| US7531551B2 (en) * | 2003-05-08 | 2009-05-12 | Ivax Pharmaceuticals S.R.O. | Polymorphs of cabergoline |
| GB0409785D0 (en) | 2004-04-30 | 2004-06-09 | Resolution Chemicals Ltd | Preparation of cabergoline |
-
2004
- 2004-04-30 GB GBGB0409785.3A patent/GB0409785D0/en not_active Ceased
-
2005
- 2005-02-18 US US11/060,991 patent/US7186837B2/en not_active Expired - Fee Related
- 2005-04-29 AU AU2005238276A patent/AU2005238276B2/en not_active Ceased
- 2005-04-29 EP EP05252709A patent/EP1591445B1/en not_active Revoked
- 2005-04-29 ES ES05252709T patent/ES2304670T3/es active Active
- 2005-04-29 CA CA2565440A patent/CA2565440C/en not_active Expired - Fee Related
- 2005-04-29 JP JP2007510117A patent/JP2007535526A/ja active Pending
- 2005-04-29 NZ NZ550925A patent/NZ550925A/en not_active IP Right Cessation
- 2005-04-29 WO PCT/GB2005/001649 patent/WO2005105796A1/en active Application Filing
- 2005-04-29 PT PT05252709T patent/PT1591445E/pt unknown
- 2005-04-29 PL PL05252709T patent/PL1591445T3/pl unknown
- 2005-04-29 AT AT05252709T patent/ATE394397T1/de active
- 2005-04-29 DE DE602005006465T patent/DE602005006465D1/de active Active
- 2005-04-29 DK DK05252709T patent/DK1591445T3/da active
- 2005-04-29 RS RSP-2008/0265A patent/RS50655B/sr unknown
- 2005-04-29 SI SI200530276T patent/SI1591445T1/sl unknown
-
2008
- 2008-06-23 HR HR20080292T patent/HRP20080292T3/xx unknown
- 2008-08-06 CY CY20081100830T patent/CY1108244T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1591445E (pt) | 2008-06-02 |
| ES2304670T3 (es) | 2008-10-16 |
| DK1591445T3 (da) | 2008-08-11 |
| GB0409785D0 (en) | 2004-06-09 |
| RS50655B (sr) | 2010-06-30 |
| US7186837B2 (en) | 2007-03-06 |
| JP2007535526A (ja) | 2007-12-06 |
| EP1591445A1 (en) | 2005-11-02 |
| EP1591445B1 (en) | 2008-05-07 |
| WO2005105796A1 (en) | 2005-11-10 |
| AU2005238276B2 (en) | 2011-08-18 |
| SI1591445T1 (sl) | 2008-08-31 |
| ATE394397T1 (de) | 2008-05-15 |
| PL1591445T3 (pl) | 2008-09-30 |
| US20050245560A1 (en) | 2005-11-03 |
| CA2565440A1 (en) | 2005-11-10 |
| AU2005238276A1 (en) | 2005-11-10 |
| DE602005006465D1 (de) | 2008-06-19 |
| CY1108244T1 (el) | 2014-02-12 |
| CA2565440C (en) | 2011-09-20 |
| NZ550925A (en) | 2010-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20080292T3 (en) | Preparation of cabergoline form i and solvate thereof | |
| MX2007007845A (es) | Sulfonilpirrolidinas, metodo para producir las mismas y su uso como medicamento. | |
| MX2009008540A (es) | Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina. | |
| HK1112238A1 (en) | Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics | |
| TW200730518A (en) | Crystalline forms of docetaxel and processes for their preparation | |
| MY145604A (en) | Process for the preparation of chiral 8-(3-aminopiperidine-1-yl)-xanthines | |
| NZ552137A (en) | New 4-benzylidene-piperidin derivatives | |
| MX2007006374A (es) | Derivados del 5-hidroxi-benzotiazol que tienen actividad agonista del adrenoreceptor-beta-2. | |
| MXPA02012795A (es) | Carvedilol. | |
| TW200613243A (en) | Novel compounds | |
| WO2006011050A3 (en) | Pyridine derivatives | |
| TW200633964A (en) | Tetralin and indane derivatives and uses thereof | |
| UA99447C2 (ru) | Способ получения силденафила | |
| MX2010003495A (es) | Derivados de quinazolinadiona, su preparacion y sus aplicaciones terapeuticas. | |
| EA200600621A1 (ru) | Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
| IS8377A (is) | Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns | |
| TW200617006A (en) | New process for the manufacture of tiotropium salts | |
| WO2006127815A3 (en) | Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists | |
| WO2007076116A3 (en) | Intermediates for preparing solifenacin | |
| TW200607810A (en) | Process to prepare camptothecin derivatives | |
| WO2006029210A3 (en) | Acyclic 1,3-diamines and uses therefor | |
| TW200505869A (en) | Thiophenylaminoimidazolines | |
| HK1126791A1 (en) | Process for the manufacture of lysobactin derivatives | |
| MXPA04008935A (es) | Procedimiento para la preparacion de la forma i cristalina de la cabergolina. | |
| MX2010011767A (es) | Derivados de benzocicloheptano y benzoxepina. |